GHK-CU 100mg Canada

Technical Specifications

Compound Name: GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex)
Quantity: 100mg per vial
Format: Lyophilized peptide complex
Peptide Length: 3 amino acids (tripeptide)
Molecular Formula: C₁₄H₂₄N₆O₄Cu
Molecular Weight: Approximately 403.93 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide complex – laboratory research use only

GHK-CU 100mg Canada is supplied as a lyophilized copper-peptide complex intended exclusively for laboratory and analytical applications. Each vial contains 100 milligrams of the GHK-Cu complex prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada.

Research Overview

GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine, histidine, and lysine complexed with copper (II). It was originally identified in human plasma and has been studied extensively in biochemical and cellular research contexts.

Research involving GHK-CU 100mg Canada typically focuses on copper transport mechanisms, extracellular matrix regulation, and gene expression pathways in laboratory models. Copper ions play a critical role in numerous enzymatic processes, and peptide-bound copper complexes are investigated for their regulatory influence on cellular metabolism.

In the scientific literature, GHK-Cu has been examined in experimental systems that explore collagen synthesis pathways, metalloproteinase activity, and oxidative stress signalling. Studies often utilize cell culture models to evaluate gene transcription patterns and protein expression changes in response to copper-peptide exposure.

GHK-CU 100mg Canada is supplied strictly for research purposes. References to biological activity reflect findings derived from in vitro and preclinical investigations and do not imply approved medical application.

Mechanism Overview

GHK-Cu functions in research settings as a copper ion carrier and signalling modulator. The histidine residue in the tripeptide coordinates with copper(II), forming a stable complex that can participate in redox and enzymatic reactions in experimental models.

In laboratory studies, GHK-Cu has been evaluated for its role in modulating gene expression associated with extracellular matrix proteins such as collagen and elastin. Researchers analyze transcriptional changes using molecular assays to determine how copper-peptide complexes influence cellular regulatory networks.

GHK-CU 100mg Canada has also been studied for its interactions with metalloproteinases and antioxidant pathways in controlled research environments. Investigations typically focus on cellular signalling cascades rather than systemic physiological effects.

Mechanistic descriptions remain confined to experimental findings and are presented for educational purposes only.

Clinical Development Context

GHK-Cu has been referenced in scientific and cosmetic research literature for several decades. Early investigations explored its biochemical properties and potential applications in tissue-related research models.

Although GHK-Cu appears in various commercial formulations internationally, GHK-CuU 100mg Canada, supplied in research-grade form, is categorized strictly as an investigational laboratory compound. It is distinct from regulated cosmetic or pharmaceutical products.

There is no Health Canada approval for GHK-Cu as a prescription medication in peptide form for systemic use. Research-grade material is intended solely for laboratory investigation.

Regulatory Status in Canada

GHK-CU 100mg Canada is classified as an investigational research peptide complex. It is not authorized by Health Canada as a therapeutic drug, natural health product, or consumer medication when supplied in research format.

The compound is provided exclusively for laboratory and analytical purposes and is not intended for human or veterinary administration.

Handling, storage, and study of GHK-CU 100mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and biological research materials. Research institutions are responsible for maintaining regulatory compliance.

Molecular and Structural Notes

GHK-Cu is a tripeptide complex in which the glycine–histidine–lysine sequence coordinates a copper (II) ion through nitrogen donor atoms. This coordination chemistry contributes to the compound’s stability and biological activity in experimental systems.

The molecular weight of approximately 403.93 g/mol reflects the combined mass of the peptide and copper ion. Its relatively small size compared to larger peptide hormones allows researchers to study minimal copper-binding motifs and their cellular effects.

GHK-CU 100mg Canada is typically characterized using analytical methods such as high-performance liquid chromatography (HPLC), atomic absorption spectroscopy to verify copper content, and mass spectrometry to confirm structural identity.

The lyophilized presentation supports compound stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is GHK-CU 100mg Canada studied for in research?
GHK-CU 100mg Canada is studied in laboratory settings to investigate copper transport, extracellular matrix regulation, and gene expression pathways.

Is GHK-Cu approved for medical use in Canada? Health Canada does not authorize research-grade GHK-Cua for therapeutic or systemic use by consumers.

What type of compound is GHK-Cu?
It is a copper-binding tripeptide complex composed of glycine, histidine, and lysine.

Does GHK-CU 100mg Canada contain additives?
Unless specified in the batch documentation, the vial contains only the lyophilized GHK-Cu complex.

Can GHK-CU 100mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

GHK-CU 100mg Canada is an investigational research peptide complex supplied solely for laboratory and analytical use. Health Canada does not approve it as a medication, therapeutic agent, or consumer product.

The information provided on this page is educational and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of GHK-CU 100mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.